1CONNIE L S, KEITH R. Powell review of the sulfonamides and trimethoprim[J]. Pediatr Rev,2000,21(2) :368-371.
2SATINDER S S,YOSHIDA T A,RODOLPHE C,et al. Gullans discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays[J]. Physiol Genomics, 2002,11 (1): 45-52.
3ROSSO JQ Del. Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations[J]. Cutis, 2004,73 (1 Suppl):29-33.
4BLASCO F, PERELLO L, LATORRE J,et al. Cobalt(Ⅱ),nickel(Ⅱ), and copper(Ⅱ) complexes of sulfanilamide derivatives: synthesis, spectroscopic studies, and antibacterial activity,crystal structure of [Co(sulfacetamide)2 (NCS)2][J]. J Inorg Biochem, 1996,61 (2): 143-154.
5VENKATESHA B,YONGSHENG S, SHARLYN J,et al. Inactivation of HIV-1 nucleocapsid protein p7 by pyridinioalkanoyl thioesters[J]. J Biol Chem,2000,275(21) :1 489-1 497.
6SPINKS C A, WYATT G M, LEE H A, et al. Molecular modeling of hapten structure and relevance to broad specificity immunoassay of sulfonamide antibiotics [J].Bioconjug Chem,1999,10(4) :583-588.
7ABRAMOVITS W, KENNEDY A J. Sulfur/sodium sulfacetamide preparations[J]. Skinmed, 2004,3 (2): 95-101.
